Industry response to the Spanish governmental Plan for the Promotion of R&D within the Pharmaceutical Industry (1986–1996)

Spain joining the European Community (European Union (EU), today) in 1986 brought it into a much more competitive environment. The Plan for the Promotion of R&D within the Pharmaceutical Industry (FARMA) was one of the R&D programmes designed by the Government within an important reform plan...

Full description

Saved in:
Bibliographic Details
Published in:Science & public policy 2004-08, Vol.31 (4), p.301-312
Main Authors: Pérez-Escolano, Isabel, París, Gonzalo
Format: Article
Language:English
Subjects:
Development
European Union
Government
Industry
Pharmaceutical industry
Policy studies
Research and development
Science and technology
Spain
Technology
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Spain joining the European Community (European Union (EU), today) in 1986 brought it into a much more competitive environment. The Plan for the Promotion of R&D within the Pharmaceutical Industry (FARMA) was one of the R&D programmes designed by the Government within an important reform plan aiming to facilitate the development of several industrial sectors. Several input-output indicators are reviewed to measure the effort made, the resources provided by the pharmaceutical companies and the outcome of the programme in the 1986–1996 period. Global resources devoted to R&D increased slightly. Domestic companies contributed more than multinationals, thus enabling the former to discover, develop and commercialise some new products in some EU markets and in the USA.
ISSN:0302-3427
1471-5430
DOI:10.3152/147154304781779958